调节胰岛素分泌和葡萄糖耐受性的神经肠道
bioRxiv : the preprint server for biology
|September 2, 2025
概括
研究人员发现从肠道到胰腺的直接神经通道. 这种途径增强胰岛素分泌,改善葡萄糖耐受性,为糖尿病治疗提供了新的途径.
科学领域:
- 神经科学
- 内分泌学
- 胃肠病学
背景情况:
- 通过肠道激素的介导,增强胰岛素分泌并影响葡萄糖代谢.
- 现有的模型无法完全解释葡萄糖调节中的复杂肠-胰腺相互作用.
- 一个直接的神经连接,肠胰腺,已被确定,但其作用是未知的.
研究的目的:
- 从肠道到胰腺的直接神经通路的识别和功能性特征.
- 研究这种神经通路在调节葡萄糖代谢和胰岛素分泌中的作用.
主要方法:
- 肠道神经元的解剖学和转录学分析.
- 确定神经回路的化学激活.
- 在体内评估葡萄糖耐受性和β细胞功能.
主要成果:
- 在十二指肠中发现了直接向胰腺发射的性神经元.
- 这些神经元是营养感应肠内神经元的下游.
- 这种途径的激活增加了β细胞的反应,增强了胰岛素分泌,并在体内改善了葡萄糖耐受性.
结论:
- 直接通过肠道到胰腺的神经通道来补充内蛋白的信号传递.
- 这种途径显著调节β细胞功能和葡萄糖代谢.
- 这种神经通路有可能改善糖尿病的血糖控制.
相关概念视频
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.4K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.4K
Cells and Secretions of the Pancreas
2.9K
The pancreas, a vital organ within the abdominal cavity, plays dual roles in the digestive and endocrine systems, collaborating with exocrine and endocrine cells to maintain optimal digestion and blood sugar levels.
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
Exocrine function is carried out by acinar cells, organized into clusters known as acini. These cells contribute to digestion by releasing substantial quantities of enzyme-rich, alkaline digestive juices.
Concurrently, the dispersed clusters of endocrine cells throughout the...
2.9K
Insulin Secretory Vesicles
5.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Hormones Regulating Blood Glucose
4.0K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
4.0K
Insulin: The Receptor and Signaling Pathways
1.5K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Glucagon-like Receptor Agonists
416
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
416


